February 13, 2026 · Form 4 insider transaction
Dreismann Heinrich bought 45,000 shares of MYNZ at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 6 days after the transaction.
Grant of restricted shares under Mainz Biomed N.V. 2025 Omnibus Incentive Plan; no cash consideration paid.; 19,700 employee stock options were granted and previously reported on a Form 3 filed January 26, 2026.